Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

189
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

GlaxoSmithKline: European Commission Authorizes Nimenix

04/27/2012 | 08:24am US/Eastern

GlaxoSmithKline PLC (>> GlaxoSmithKline plc), the drug company, said Friday that the European Commission has granted marketing authorization for Nimenrix, Meningococcal group A, C, W-135 and Y conjugate vaccine, for active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135 and Y.

-Shares at 1207 GMT, up a penny, or 0.04%, at 1,420.5 pence valuing the company at GBP71.61 billion.

-By Rory Gallivan, Dow Jones Newswires; 44-20-7842-9411; rory.gallivan@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc
React to this article
Latest news on GLAXOSMITHKLINE PLC
03/05 GLAXOSMITHKLINE PAKISTAN : Material information of GlaxoSmithKline Pakistan Limi..
03/04 GLAXOSMITHKLINE : Zofran Lawsuit News: Attorneys Outline Zofran Research
03/04 YASUCHIKA HASEGAWA : Weber to replace Hasegawa as CEO of Takeda Pharmaceutical
03/04 GLAXOSMITHKLINE : India pharmaceutical giant buys Glaxo's Aussie opiates busines..
03/03 SUN PHARMACEUTICAL : Buys gsk opiates australia business
03/03 GLAXOSMITHKLINE : In Brief : Deals finalised by GSK and Novartis
03/03 GLAXOSMITHKLINE : Zofran Lawsuit News: Attorneys Outline Zofran Research
03/03 Agenus Posts Fourth Quarter and Full Year 2014 Financial Results
03/03 India's Sun Pharma to buy Glaxo's opiates business in Australia
03/02 GLAXOSMITHKLINE : Health and Human Services Department (HHS); Food and Drug Admi..
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF